Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

davita inc. - DVA

DVA

Close Chg Chg %
164.12 1.39 0.84%

Closed Market

165.51

+1.39 (0.84%)

Volume: 612.12K

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: davita inc. - DVA

DVA Key Data

Open

$164.90

 Day Range

163.76 - 166.27

52 Week Range

98.26 - 168.47

 Market Cap

$13.46B

Shares Outstanding

82.00M

 Public Float

78.30M

Beta

0.89

 Rev. Per Employee

N/A

P/E Ratio

17.69

 EPS

$9.52

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

967.68K

  

DVA Performance

1 Week
 
 3.23%
 
1 Month
 
 5.43%
 
3 Months
 
 7.48%
 
1 Year
 
 66.74%
 
5 Years
 
 128.35%
 

DVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About davita inc. - DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DVA At a Glance

DaVita, Inc.
2000 16th Street
Denver, Colorado 80202-7198
Phone 1-720-631-2100 Revenue 12.14B
Industry Medical/Nursing Services Net Income 691.54M
Sector Health Services 2023 Sales Growth 4.567%
Fiscal Year-end 12 / 2024 Employees 70,000
View SEC Filings

DVA Valuation

P/E Current 17.695
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 14.116
Price to Sales Ratio 0.804
Price to Book Ratio 8.811
Price to Cash Flow Ratio 4.73
Enterprise Value to EBITDA 9.414
Enterprise Value to Sales 1.82
Total Debt to Enterprise Value 0.503

DVA Efficiency

Revenue/Employee 173,430.671
Income Per Employee 9,879.071
Receivables Turnover 5.025
Total Asset Turnover 0.688

DVA Liquidity

Current Ratio 1.188
Quick Ratio 1.133
Cash Ratio 0.18

DVA Profitability

Gross Margin 25.329
Operating Margin 13.188
Pretax Margin 9.696
Net Margin 5.696
Return on Assets 3.918
Return on Equity 78.209
Return on Total Capital 5.681
Return on Invested Capital 5.87

DVA Capital Structure

Total Debt to Total Equity 1,052.595
Total Debt to Total Capital 91.324
Total Debt to Total Assets 63.092
Long-Term Debt to Equity 1,003.575
Long-Term Debt to Total Capital 87.071
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Davita Inc. - DVA

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
11.55B 11.62B 11.61B 12.14B
Sales Growth
+1.42% +0.59% -0.08% +4.57%
Cost of Goods Sold (COGS) incl D&A
8.62B 8.65B 8.94B 9.07B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
630.43M 680.62M 732.60M 745.44M
Depreciation
616.63M 667.75M 721.13M 736.47M
Amortization of Intangibles
13.81M 12.86M 11.47M 8.97M
COGS Growth
+1.05% +0.39% +3.34% +1.38%
Gross Income
2.93B 2.97B 2.67B 3.07B
Gross Income Growth
+2.54% +1.17% -10.05% +15.27%
Gross Profit Margin
+25.38% +25.53% +22.98% +25.33%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.25B 1.20B 1.36B 1.47B
Research & Development
- - - -
-
Other SG&A
1.25B 1.20B 1.36B 1.47B
SGA Growth
+13.08% -4.19% +13.37% +8.77%
Other Operating Expense
- - - -
-
Unusual Expense
86.39M 2.48M (5.92M) 22.88M
EBIT after Unusual Expense
1.60B 1.77B 1.32B 1.58B
Non Operating Income/Expense
17.71M 30.28M (6.90M) (106.05M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
26.92M 26.94M 26.52M 27.86M
Interest Expense
297.03M 279.75M 345.29M 294.98M
Interest Expense Growth
-31.75% -5.82% +23.43% -14.57%
Gross Interest Expense
314.97M 295.02M 357.96M 304.16M
Interest Capitalized
17.94M 15.28M 12.68M 9.18M
Pretax Income
1.32B 1.52B 966.28M 1.18B
Pretax Income Growth
+10.27% +15.19% -36.37% +21.82%
Pretax Margin
+11.41% +13.07% +8.32% +9.70%
Income Tax
313.93M 306.73M 198.09M 220.12M
Income Tax - Current - Domestic
68.61M 232.14M 257.52M 238.44M
Income Tax - Current - Foreign
17.48M 14.25M 16.25M 21.01M
Income Tax - Deferred - Domestic
225.83M 64.87M (78.69M) (39.87M)
Income Tax - Deferred - Foreign
2.01M (4.53M) 3.00M 535.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
26.92M 26.94M 26.52M 27.86M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.00B 1.21B 768.19M 956.98M
Minority Interest Expense
221.03M 233.31M 221.24M 265.44M
Net Income
783.29M 978.45M 546.95M 691.53M
Net Income Growth
+10.82% +24.91% -44.10% +26.44%
Net Margin Growth
+6.78% +8.42% +4.71% +5.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
783.29M 978.45M 546.95M 691.53M
Preferred Dividends
- - - -
-
Net Income Available to Common
783.29M 978.45M 546.95M 691.53M
EPS (Basic)
6.5385 9.2982 5.8817 7.6169
EPS (Basic) Growth
+23.50% +42.21% -36.74% +29.50%
Basic Shares Outstanding
119.80M 105.23M 92.99M 90.79M
EPS (Diluted)
6.3878 8.8992 5.7072 7.4213
EPS (Diluted) Growth
+21.15% +39.32% -35.87% +30.03%
Diluted Shares Outstanding
122.62M 109.95M 95.83M 93.18M
EBITDA
2.31B 2.45B 2.05B 2.35B
EBITDA Growth
-2.37% +5.90% -16.56% +14.73%
EBITDA Margin
+20.04% +21.10% +17.62% +19.33%

Snapshot

Average Recommendation HOLD Average Target Price 163.00
Number of Ratings 11 Current Quarters Estimate 2.144
FY Report Date 12 / 2024 Current Year's Estimate 9.697
Last Quarter’s Earnings 2.59 Median PE on CY Estimate N/A
Year Ago Earnings 8.47 Next Fiscal Year Estimate 11.357
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 4 7 7
Mean Estimate 2.14 2.41 9.70 11.36
High Estimates 2.31 2.51 9.94 11.86
Low Estimate 2.07 2.24 9.51 10.59
Coefficient of Variance 3.83 4.93 1.41 3.99

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 1 1 0
HOLD 7 6 7
UNDERWEIGHT 2 3 2
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Davita Inc. - DVA

Date Name Shares Transaction Value
Aug 23, 2024 Javier J. Rodriguez Chief Executive Officer; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 23, 2024 Javier J. Rodriguez Chief Executive Officer; Director 937,835 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $152.17 per share 142,710,351.95
Aug 23, 2024 Javier J. Rodriguez Chief Executive Officer; Director 1,119,763 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $152.17 per share 170,394,335.71
Aug 23, 2024 Javier J. Rodriguez Chief Executive Officer; Director 1,453,929 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $67.8 per share 98,576,386.20
Aug 20, 2024 Barbara Jean Desoer Director 333 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Dennis W. Pullin Director 300 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Pamela M. Arway Director 24,574 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Jason M. Hollar Director 4,234 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Charles G. Berg Director 18,973 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Gregory J. Moore Director 5,442 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Michael D. Staffieri Chief Operating Officer, DKC 209,365 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $150.17 per share 31,440,342.05
Aug 20, 2024 Michael D. Staffieri Chief Operating Officer, DKC 241,945 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $150.03 per share 36,299,008.35
Aug 20, 2024 Adam H. Schechter Director 3,321 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Wendy Lee Schoppert Director 1,516 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Phyllis R. Yale Director 15,692 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 20, 2024 John M. Nehra Director 366 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 18, 2024 Michael D. Staffieri Chief Operating Officer, DKC N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 18, 2024 Michael D. Staffieri Chief Operating Officer, DKC 68,123 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $139.21 per share 9,483,402.83
Mar 11, 2024 Joel Ackerman CFO and Treasuer 173,952 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $134.65 per share 23,422,636.80
Mar 11, 2024 Joel Ackerman CFO and Treasuer 156,803 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $134.65 per share 21,113,523.95

Davita Inc. in the News